BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 103 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $37,210,000 | -65.7% | 990,943 | -63.9% | 1.00% | -65.0% |
| Q2 2018 | $108,429,000 | +52.2% | 2,743,647 | -6.3% | 2.84% | +42.5% |
| Q1 2018 | $71,224,000 | +911.0% | 2,927,449 | +1021.1% | 2.00% | +752.6% |
| Q4 2017 | $7,045,000 | -69.2% | 261,134 | -57.3% | 0.23% | -46.5% |
| Q3 2017 | $22,886,000 | +662.9% | 612,268 | +410.2% | 0.44% | +189.4% |
| Q2 2017 | $3,000,000 | – | 120,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |